We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genes behind Gestation Length and Preterm Delivery Identified

By LabMedica International staff writers
Posted on 21 Sep 2017
Despite evidence that genetic factors contribute to the duration of gestation and the risk of preterm birth, robust associations with genetic variants have not been identified. More...
Preterm birth and gestational duration in general, is a complicated phenotype that is affected by both maternal and fetal genomes.

The definition of preterm birth as a dichotomous trait on the basis of a somewhat arbitrary cutoff of 37 weeks of gestation, rather than time of birth for a specified level of fetal maturity or as a continuous trait limits the interpretation of data and reduces the statistical power to detect association.

An international team of scientists working with those at the University of Gothenburg (Sweden) based a study on genetic data and information on gestation length for 43,568 women of mainly European origin. The information was made available to the team by 23andMe (Mountain View, CA, USA), one of the world's largest players in DNA testing for personal use. The company's tests are based on submitted saliva samples. Female participants who had given birth also had to state how long their pregnancies had been.

The reference group consists of 8,643 women in Denmark, Finland and Norway. The information on them comes from traditional health registers. A crucial factor in this study was the combination of a very large group, and a register-based group for which the results could be replicated. The genome-wide association studies showed that there are four genes with a clear link to gestation length: Early B-Cell Factor 1 (EBF1), Eukaryotic Elongation Factor, Selenocysteine-TRNA Specific (EEFSEC), Angiotensin II Receptor Type 2 (AGTR2) and Wnt Family Member 4 (WNT4). Commonly occurring variants of the first three genes also appeared to have a determining influence on the likelihood of preterm birth that is delivery before 37 full weeks. Variants of a further two genes could also be associated with gestation length, which was most evident in the reference group.

Bo Jacobsson, MD, PhD, a professor of Obstetrics and a senior co-author of the study said, “Our findings open up a window on better understanding of how human gestation length is governed and why labor might start too soon. It's less about predicting who will end up in one situation or the other; now we need to move to the lab bench and conduct some studies into how this works together with various environmental factors.” The study was published on September 6, 2017, in The New England Journal of Medicine.

Related Links:
University of Gothenburg
23andMe

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Automatic CLIA Analyzer
Shine i6000
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.